tbuckley/cabot-search huggingface dataset:
SAT-243 Time course of onset, incidence and prevalence of gastrointestinal adverse events with HTD1801 (Berberine Ursodeoxycholate) in patients with MASH and T2DM
Authors: Guy Neff, Stephen A. Harrison, Nadege Gunn, Abigail Flyer, Kui Liu, Alexander Liberman
Journal: Journal of Hepatology (2024)
WED-209 Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD
Authors: Lars Verschuren, Eveline Gart, Anne Linde Mak, Arianne van Koppen, Serdar Özsezen, Andre Boonstra, Joanne Verheij, Lise Lotte Gluud, Onno Holleboom, Maarten Tushuizen, Roeland Hanemaaijer
Journal: Journal of Hepatology (2024)
THU-274 Targeting mitochondrial complex I modulates lipid metabolism, inflammation and hepatic fibrosis in a MCD-diet model of benign steatosis
Authors: Francesca Protopapa, Laura Giuseppina Di Pasqua, Michelangelo Trucchi, Erica Scotti, Peng Sun, Stefan Günther Kauschke, Mariapia Vairetti, Anna Cleta Croce, Andrea Ferrigno
Journal: Journal of Hepatology (2024)
THU-278 Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model
Authors: Radina Kostadinova, Simon Ströbel, Li Chen, Katia Fiaschetti-Egli, Jana Gadient, Agnieszka Pawlowska Pawlowska, Louis Petitjean, Manuela Bieri, Eva Thoma, Mathieu Petitjean
Journal: Journal of Hepatology (2024)
TOP-216 The three strain probiotics for metabolic dysfunction-associated steatotic liver disease improvement: a parallel, double-blind, randomized, placebo-controlled trial
Authors: Sung-Min Won, Sang Jun Yoon, Jin-Ju Jeong, SatyaPriya Sharma, Ki Kwang Oh, Dong Hoon Yang, Hyun Joon Park, Sang Gyune Kim, Moon Young Kim, Ki Tae Suk
Journal: Journal of Hepatology (2024)
FRI-017 Fibrosis activity versus disease stage: systemic markers of fibrosis activity have better prognostic performance than the liver biopsy in patients with alcohol-related liver disease
Authors: Stine Johansen, Mads Israelsen, Katrine Lindvig, Katrine Thorhauge, Johanne Kragh Hansen, Camilla Dalby Hansen, Ida Ziegler Spedtsberg, Helle Schnefeld, Peter Andersen, Ida Falk Villesen, Katrine Tholstrup Bech, Nikolaj Torp, Diana Leeming, Torben Hansen, Morten Karsdal, Maja Thiele, Aleksander Krag
Journal: Journal of Hepatology (2024)
WED-294 The use of the FibroScan-AST score and AST to pre-identify metabolic dysfunction-associated steatohepatitis patients with active fibrogenesis in a Phase 1b open-label clinical trial
Authors: Mazen Noureddin, Eric Lawitz, Naim Alkhouri, Zeid Kayali, Madhavi Rudraraju, Edward Mena, Rohit Loomba, Tarek Hassanein, Parvez Mantry, Mohammad Siddiqui, Kathryn Jean Lucas, Garry Reiss, Oni Aneiros, Dawn Farno, Shawna Differding, Debbie Marshall, Jaime Biracree, Bruno Devadas, Praveena Reddy, Chetna Patel, Jennifer Tsau, Michael Chen, Michelle Mendoza, Scott Butler, Holly Oakley, Wendi Lichtenberger, Shannon Hambridge, Paresh Thakker, Haakan Wennbo, Peter Nagy, Zoltan Derdak
Journal: Journal of Hepatology (2024)
THU-260 Serum thrombospondin-2 and insulin -like growth factor binding protein 7 predict liver fibrosis and fibrosis regression in patients with MASLD post bariatric surgery
Authors: Rambabu Surabattula, Pierre Bel Lassen, Sudha Rani Myneni, Aron-Wisnewsky Judith, Laurent Genser, Jean-Daniel Zucker, Karine Clément, Detlef Schuppan
Journal: Journal of Hepatology (2024)
THU-221 Association of non-invasive tests (NITs) with genetic polymorphism in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
Authors: Zobair Younossi, James M. Estep, Zohal Zekrya, Sean Felix, Brian Lam, Zaid Younossi, Andrei Racila, Maria Stepanova
Journal: Journal of Hepatology (2024)
SAT-203 Pegozafermin added to background GLP-1 therapy in patients with metabolic dysfunction-associated steatohepatitis with F2/F3 fibrosis: ENLIVEN 48-week extension data
Authors: Arun J. Sanyal, Manal F. Abdelmalek, Kris V. Kowdley, Naim Alkhouri, Stephen A. Harrison, Jörn M. Schattenberg, Mildred D. Gottwald, Shibao Feng, Germaine D. Agollah, Cynthia L. Hartsfield, Hank Mansbach, Maya Margalit, Rohit Loomba
Journal: Journal of Hepatology (2024)
SAT-206 Improvements in MACK-3, a diagnostic test for active metabolic dysfunction-associated steatohepatitis, parallel response to lanifibranor therapy
Authors: Michael Cooreman, Sven Francque, Philippe Huot-Marchand, Lucile Dzen, Martine Baudin, Jean-Louis Junien, Pierre Broqua, Manal F. Abdelmalek, Jerome Boursier
Journal: Journal of Hepatology (2024)
WED-341 EUS-guided assessment of steatotic liver disease in bariatric surgery patients
Authors: Paula Fernandez Alvarez, Rafael Romero Castro, Maria Tous Romero, Alvaro Gutierrez Dominguez, Félix Conde Martín, Juan José Ríos Martín, Victoria Alejandra Jiménez García, Eduardo Dominguez Adame, Patricia Cordero Ruiz, Francisco Luis Bellido Muñoz, Manuel Rodríguez Téllez, Angel Caunedo Alvarez, Isabel Carmona Soria
Journal: Journal of Hepatology (2024)
FRI-254 Global prevalence, clinical characteristics, histology and outcomes of PNPLA3 I148M variant in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
Authors: Matheus Souza, Ivanna Diaz, Lubna Al-Sharif, Cristiane Villela-Nogueira, Alessandro Mantovani
Journal: Journal of Hepatology (2024)
FRI-196 Association between liver histology and long-term clinical outcomes in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease in Sweden: a real-world cohort study (BRIDGE-MASH)
Authors: Ying Shang, Johan Vessby, Kamal Kant Mangla, Elisabeth de Laguiche, Mattias Ekstedt, Hannes Hagstrom
Journal: Journal of Hepatology (2024)
WED-262 AI-assisted, quantitative digital pathology-based continuous fibrosis scores perform better than conventional pathology in documenting fibrosis reduction
Authors: Vlad Ratziu, Louis Petitjean, Raluca Pais, Judith Aron-Wisnewsky, Li Chen, Leila Kara, Frederic Charlotte, Pierre Bedossa, Mathieu Petitjean
Journal: Journal of Hepatology (2024)
FRI-223 Cost-effectiveness of one-time screening for advanced hepatic fibrosis using FIB-4 based two-step algorithm in the general population
Authors: Eileen Yoon, Jihyun An, Ha Il Kim, Joo Hyun Sohn, Bo-Kyeong Kang, Eun Chul Jang, Huiyul Park, Hye-Lin Kim, Sang Bong Ahn, Joo Hyun Oh, Dae Won Jun
Journal: Journal of Hepatology (2024)
THU-458 No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC
Authors: Francisca Copil, Claudia Campani, Marie Lequoy, Philippe Sultanik, Lorraine Blaise, Mathilde Wagner, Nathalie Ganne-Carrié, Violaine Ozenne, Jean Charles Nault, Dominique Thabut, Vlad Ratziu, Manon Allaire
Journal: Journal of Hepatology (2024)
THU-501 Safety and efficacy preliminary analysis of first-line systemic therapy with atezolizumab plus bevacizumab in Spanish patients with unresectable hepatocellular carcinoma not previously treated with systemic therapy: phase IIIb ATHECA trial
Authors: María Reig, Natalia Luque, José Luis Lledó, Ana Matilla, Jose Luis Montero, Roberto Pazo-Cid, Maria Varela, Mar Borràs, Jose-Manuel Ordóñez, Josep Maria Argemi, Jordi Bruix, Carlos Gomez-Martin, Raquel Pérez-López, Jordi Rimola, Bruno Sangro, Javier Sastre
Journal: Journal of Hepatology (2024)
WED-278 MASLD assessment using a novel point of care device the Hepatoscope™ in diabetes and obesity clinics
Authors: Cyrielle Caussy, Bruno Vergès, Rouland Alexia, Bérénice Ségrestin, Dominique Delaunay, Sybil Charrière, Emmanuel Disse, Philippe Moulin, Jean-Michel Petit
Journal: Journal of Hepatology (2024)
FRI-314 Plasminogen activator inhibitor-1 (PAI-1) is associated with hepatic steatosis improvement after lifestyle intervention in overweight/obese subjects with metabolic-dysfunction associated steatotic liver disease
Authors: Chiara Rosso, Marta Guariglia, Angelo Armandi, Gian Paolo Caviglia, Eleonora Dileo, Francesca Saba, Gabriele Castelnuovo, Marilu’ Benedetta Scalici, Nuria Pérez Diaz del Campo, Kamela Gjini, Maria Lorena Abate, Antonella Olivero, Mirko Parasiliti-Caprino, Simona Bo, Elisabetta Bugianesi
Journal: Journal of Hepatology (2024)
Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms
Authors: Michael Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Jacqueline Barrientos, Seema A. Bhat, James Blachly, Alessandro Broccoli, Timothy Call, Claire Dearden, Sascha Dietrich, Monica Else, Narendranath Epperla, Andrei Fagarasanu, Brunangelo Falini, Francesco Forconi, Alessandro Gozzetti, Paul Hampel, David J. Hermel, Sunil Iyengar, James B. Johnston, Gunnar Juliusson, Robert J. Kreitman, Francesco Lauria, Gerard Lozanski, Christopher C. Oakes, Sameer A. Parikh, Jae Park, Graeme Quest, Kanti Rai, Farhad Ravandi, Tadeusz Robak, Kerry A. Rogers, Alan Saven, John F. Seymour, Tamar Tadmor, Martin S. Tallman, Constantine S. Tam, Enrico Tiacci, Xavier Troussard, Bernhard Wörmann, Clive S. Zent, Thorsten Zenz, Pier Luigi Zinzani
Journal: Leukemia (2024)
WED-318-YI Steatotic liver disease in diabetic patients: more serious diabetes mellitus, more serious liver disease
Authors: Zülal İstemihan, Fatih Bektaş, Ali Emre Bardak, Cansu Kızıltaş, Gamze Kemeç, Kanan Nuriyev, Aynure Rüstemzade, Sezen Genç Uluçeçen, Hülya Hacışahinoğulları, Kubilay Karşıdağ, Bilger Çavuş, Asli Çifcibasi Örmeci, Filiz Akyuz, Kadir Demir, Fatih Beşışık, Sabahattin Kaymakoğlu
Journal: Journal of Hepatology (2024)
THU-286 PNPLA3 p.I148M variant affects lipid droplets number and size in patient-derived liver organoids
Authors: Elia Casirati, Alessandro Cherubini, Laura Cerami, Fabrizia Carli, Amalia Gastaldelli, Daniele Prati, Daniele Dondossola, Luca Valenti
Journal: Journal of Hepatology (2024)
TOP-217 A randomized, placebo-controlled phase Ib/IIa trial to evaluate the safety, tolerability, and efficacy of BGT-002, an adenosine triphosphate citrate lyase inhibitor in patients with NAFLD: interim analysis
Authors: Yue Hu, Hong Zhang, Guoyue Lv, Fajun Nan, Jingya Li, Yangming Zhang, Dandan Wu, Yanhua Ding, Junqi Niu
Journal: Journal of Hepatology (2024)
WED-211 Combination of Liverfast (LF) and Liver Stiffness Measurement (LSM) using fibroscan uutperforms FIB-4 and LSM, for the identification of MASLD advanced fibrosis (AF) in patients with type 2 diabetes (T2D)
Authors: Julie Dupuy, Adèle Delamarre, Paul Hermanbessiere, Ronald Quiambao, Parvez Mantry, Imtiaz Alam, Mona Munteanu, Victor de Ledinghen
Journal: Journal of Hepatology (2024)
THU-254-YI Differential gene expression profiles of liver tissue, subcutaneous and visceral adipose tissue delineates severity of MASLD in heavily obese patients
Authors: Lina Jegodzinski, Darko Castven, Diana Becker, Juliana Marques Affonso, Alvaro Mallagaray de Benito, Lorena Rudolph, Ashok Kumar Rout, Matthias Laudes, Rainer Günther, Stefan Schreiber, Svenja Meyhöfer, Friedhelm Sayk, Thomas Becker, Jan Henrik Beckmann, Ulrich L. Günther, Witigo von Schönfels, Jens U. Marquardt
Journal: Journal of Hepatology (2024)
WED-233-YI The single nucleotide polymorphism rs780094 C&gt;T in the glucokinase regulator gene (GCKR) is associated with hepatic steatosis improvement after lifestyle intervention in overweight/obese subjects with metabolic dysfunction-associated steatotic liver disease
Authors: Eleonora Dileo, Chiara Rosso, Mariagrazia Tatoli, Gabriele Castelnuovo, Gian Paolo Caviglia, Angelo Armandi, Nuria Pérez Diaz del Campo, Marta Guariglia, Francesca Saba, Maria Lorena Abate, Antonella Olivero, Fabio Bioletto, Mirko Parasiliti-Caprino, Simona Bo, Elisabetta Bugianesi
Journal: Journal of Hepatology (2024)
FRI-280 Dynamic of cardiometabolic components are highly correlated with the risk of hypertension and diabetes among patients with metabolic dysfunction-associated steatotic liver disease
Authors: Chin-I Shih, Ming-Lun Yeh, Kuan-Ta Wu, Meng-Hsuan Hsieh, Jeng-Fu Yang, Yi-Yu Chen, Wei-Lun Tsai, Wen-Chi Chen, Po-Cheng Liang, Yu-Ju Wei, Pei-Chien Tsai, Ya-Yun Cheng, Po-Yao Hsu, Ming-Yen Hsieh, Yi-Hung Lin, Tyng-Yuan Jang, Chih-Wen Wang, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Chi-Kung Ho, Wan-Long Chuang, Wei-Ting Chang, Ming-Lung Yu
Journal: Journal of Hepatology (2024)
FRI-490-YI Intratumoural microbiome alterations predict postoperative recurrence and mortality in hepatocellular carcinoma after hepatic resection
Authors: Saisai Zhang, Fung Yu Huang, Meng Zhao, Tan-To Cheung, Tiffany Wong, Danny Ka-HoWong, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Journal: Journal of Hepatology (2024)
SAT-033 Three- vs. six-monthly measurement of phosphatidylethanol (PEth) in the detection of alcohol use relapse after liver transplantation (RAULT) for alcohol-associated liver disease (ALD)
Authors: Lubomir Skladany, Svetlana Adamcova Selcanova, Natalia Kubanek, Daniela Žilinčanová, Daniel Jan Havaj, Karolina Sulejova, Michal Patarak, Lubos Chvala, Juan Pablo Arab, Tomáš Koller
Journal: Journal of Hepatology (2024)
TOP-004 Impact of MELD 3.0 on waitlist outcomes of metabolic dysfunction-associated steatohepatitis cirrhosis among liver transplant waitlist registrants
Authors: Benedix Sim, Wen Hui Lim, Darren Jun Hao Tan, Cheng Han Ng, Nicholas Syn, Benjamin Nah, Benjamin Koh, Jieling Xiao, Christen Ong, Jia Hong Koh, Daniel Tung, Daniel Huang, Mohammad Shadab Siddiqui, Mark Muthiah, Margaret Teng
Journal: Journal of Hepatology (2024)
TOP-511 Trends and evolution of hepatocellular carcinoma due to etiological shift from 2005 to 2020 in Germany: nationwide population-based study
Authors: Josune Cabello Calleja, Wenyi Gu, Robert Schierwagen, Maximilian Joseph Brol, Frank Erhard Uschner, Florian Rennebaum, Sara Noemi Reinartz Groba, Michael Praktiknjo, Jonel Trebicka
Journal: Journal of Hepatology (2024)
SAT-485 Utility of the GAAD algorithm in the screening of hepatocellular carcinoma in a prospective cohort of at-risk patients: preliminary results
Authors: Emily Larrea, Gemma Serrano, Gloria Ruiz-Fernández, Eva Marín, Joaquín Poza, Marta Abadía, Clara Amiama, Irene González-Díaz, Carmen Amor, Paula Torrijos, Rafael Gayoso, José Carlos Erdozaín, María Sánchez-Azofra, Marta Cuadros, Patricia Mayor, Yolanda Zarauza, Rubén Fernández-Martos, Alberto Cerpa, Pilar Castillo, Miriam Romero, Araceli Garcia-Sanchez, Francisco Javier Garcia-Samaniego, Susana Cano, Verónica Ucle, Sonia Álvarez, Mariana Serrés, María Sanz de Pedro, Antonio Buño, Antonio Olveira
Journal: Journal of Hepatology (2024)
TOP-512-YI Metformin as a protective factor against hepatocellular carcinoma in chronic hepatitis C patients achieving sustained virologic response: a long-term follow-up study
Authors: Henar Calvo, Lorena Jara, Irene Villarino, Marta Quiñones, Ruben Alvarado, Eva Martinez, Vanessa Díaz, Maria Luisa Gutiérrez, Joaquin Miquel, Eduardo Sanz de Villalobos, Miguel Torralba, Sonia Albertos Rubio, Conrado Fernández-Rodríguez, Juan Ramón Larrubia
Journal: Journal of Hepatology (2024)
SAT-031-YI Evolution of pre liver transplant cardiovascular risk factors and cardiac work-up: impact on post-transplant events
Authors: Margherita Saracco, Chiara Manuli, Roberta Lasco, Mimma Bonomo, Bruna Lavezzo, Gian Paolo Caviglia, Donatella Cocchis, Mauro Giorgi, Antonio Ottobrelli, Renato Romagnoli, Silvia Martini
Journal: Journal of Hepatology (2024)
SAT-501-YI The CRAFITY score to predict hepatocellular carcinoma disease control rate at month 12 in patients undergoing transarterial chemoembolization
Authors: Rhea Veelken, Anne Olbrich, Sabine Lieb, Aaron Schindler, Adam Herber, Sebastian Ebel, Timm Denecke, Thomas Berg, Florian van Bommel
Journal: Journal of Hepatology (2024)
SAT-515 Cholangiocarcinoma across England: evidence of regional, socioeconomic, and temporal variations in incidence, survival, routes to diagnosis and treatment
Authors: Sophie Jose, Amy Zalin, Daniela Tataru, Craig Knott, Lizz Paley, Helen Morement, Roger Cherry, Kwok Wong, Mireille Toledano, Shahid Khan
Journal: Journal of Hepatology (2024)
FRI-467 Efficacy of WNTinib, a novel selective therapeutic for CTNNB1 mutant tumors, in preclinical models of hepatoblastoma
Authors: Ugne Balaseviciute, Jordi Abril-Fornaguera, Júlia Huguet-Pradell, Alex Rialdi, Elisa Fernández-Martínez, Albert Gris-Oliver, Agavni Mesropian, Gulay Ulukaya, Dan Hasson, Ieva Keraite, Roser Pinyol, Swan N. Thung, Ernesto Guccione, Josep Llovet
Journal: Journal of Hepatology (2024)
SAT-524 Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study
Authors: Carla De Benedittis, Francesca Caldarone, Maia Lepore, Angelo Strada, Michela Burlone, Cristina Rigamonti, Carlo Smirne, Matteo Nazzareno Barbaglia, Rosalba Minisini, Mario Pirisi
Journal: Journal of Hepatology (2024)
SAT-482 A modified Charlson comorbidity index to improve management of patients with hepatocellular carcinoma: a step towards precision medicine
Authors: Eleonora Alimenti, Massimo Iavarone, Lorenzo Canova, Elia Fracas, Barbara Antonelli, Anna Maria Ierardi, Silvia Crespi, Arianna Zefelippo, Angelo Sangiovanni, Pietro Lampertico
Journal: Journal of Hepatology (2024)
FRI-464 Caspases compromise SLU7 and UPF1 stability and nonsensemediated RNA decay activity during hepatocarcinogenesis
Authors: Carla Rojo, María Gárate-Rascón, Miriam Recalde, Ane Álava, María Elizalde, Maria Azkona, Elisabet Guruceaga, Amaya Lopez-Pascual, Maria U. Latasa, Bruno Sangro, Maite G. Fernandez-Barrena, Matías A. Avila, Maria Arechederra, Carmen Berasain
Journal: Journal of Hepatology (2024)
SAT-019 Recipient donor sex constellation differences in outcome after liver transplantation for hepatocellular carcinoma-an ELTR study
Authors: Christian Magyar, Noah Arteaga, Giacomo Germani, Vincent Karam, René Adam, Lucienne Christen, Federico Storni, Corina Kim-Fuchs, Anja Lachenmayer, Guido Beldi, Daniel Candinas, Pompilia Radu, Birgit Schwacha-Eipper, Annalisa Berzigotti, Vanessa Banz, for the European Liver and Intestine Transplant Association (ELITA)
Journal: Journal of Hepatology (2024)
FRI-465 The fetal insulin receptor isoform stimulates liver carcinogenesis through non-cell autonomous mechanisms
Authors: Fanny Leandre, Akila Hamimi, Cécile Godart, Isabelle Lagoutte, Anthony Caldiero, Sandra Pinto, Alexandre Alves, Sabine Colnot, Angélique Gougèlet, Christèle Desbois-Mouthon
Journal: Journal of Hepatology (2024)
SAT-543 The surface antigens of circulating small extracellular vesicles, as non-invasive markers of the immune mechanisms involved in liver diseases according to etiology
Authors: Albert Guinart-Cuadra, Anna Brujats, Manuel de la Torre, Rubén Osuna-Gómez, Elisabet Cantó, Maria Poca, Eva Roman, Javier Fajardo, Eva Santamaria, German Soriano, Càndid Villanueva, Àngels Escorsell, Cristina Gely, Josep Maria Argemi, Delia D'Avola, Silvia Vidal, Edilmar Alvarado-Tapias
Journal: Journal of Hepatology (2024)
WED-016 Continuous hemodiafiltration prevents sinusoidal endothelial failure during extended ex situ normothermic perfusion of porcine livers
Authors: Jordi Vengohechea Llorens, Javier Muñoz, Marina Vendrell, Josep Marti Sanahuja, Joaquim Albiol, Javier Salinas, Aida Vaquero-Rey, Amelia Judith Hessheimer, Constantino Fondevila
Journal: Journal of Hepatology (2024)
FRI-551 β-arrestin2 promotes cytoskeleton polymerization through RhoA-Diaph2 signaling to activate YAP to mediate liver regeneration after hepatectomy in mice
Authors: Genshu Wang, Wenfeng Zhu, Xiaolong Chen, Xiaowen Wang, Xuejiao Li, Haoqi Chen, Zhilong Liu, Zhiwei Chen
Journal: Journal of Hepatology (2024)
TOP-002 Validation of the gender-equity model for liver allocation (GEMA) in a nationwide cohort of liver transplant candidates in Spain
Authors: Manuel Rodríguez-Perálvarez, Gloria de la Rosa, Antonio M. Gómez-Orellana, Victoria Aguilera Sancho, Teresa Pascual-Vicente, Sheila Pereira, María Luisa Ortiz, Giulia Pagano, Francisco Suárez, Rocio González-Grande, Alba Cachero, Santiago Tomé, Mónica Barreales Valbuena, Rosa Martin-Mateos, Sonia Pascual, Mario Romero Cristóbal, Itxarone Bilbao, Carmen Alonso Martin, Elena Oton, Maria Luisa Gonzalez Dieguez, María Dolores Espinosa Aguilar, Ana Arias, Gerardo Blanco, Sara Lorente Perez, Antonio Cuadrado, Amaya Redín García, Clara Sánchez Cano, Carmen Cepeda Franco, Jose Antonio Pons, Jordi Colmenero, Alejandra Otero Ferreiro, Nerea Hernández Aretxabaleta, Sarai Romero Moreno, Maria Rodriguez Soler, César Hervás, Mikel Gastaca
Journal: Journal of Hepatology (2024)
THU-189 Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry
Authors: Flor M Fernandez-Gordón Sánchez, Sergio Rodriguez-Tajes, María Carlota Londoño, Álvaro Díaz-González, Margarita Sala Llinás, Manuel Romero-Gómez, Javier Martínez González, Judith Gómez-Camarero, Manuel Hernández Guerra, Mercedes Vergara, Tom Stephane Fournot, Raul J. Andrade, Silvia Goñi Esarte, Juan Turnes Vázquez, Montserrat García-Retortillo, Marina Berenguer, Elena Gómez-Domínguez
Journal: Journal of Hepatology (2024)
SAT-554-YI Cellular immunity changes induced by COVID-19 vaccines in patients with chronic liver disease
Authors: Carolina Palma, Mariana Moura Henrique, André Simão, Ana Godinho-Santos, Miguel Cardoso, Diogo Fernandes, Sofia Carvalhana, Miguel Moura, João Gonçalves, Helena Cortez-Pinto, Rui E. Castro
Journal: Journal of Hepatology (2024)
SAT-551 F-actin in autoimmune liver diseases: a comprehensive evaluation of diagnostic potential using a newly-developed autoimmune liver line immunoassay
Authors: Christos Liaskos, Tanja Seifert, Eleni Patrikiou, Marco Kai, Alexandra Tsirogianni, Christina Tsigalou, Dimitrios Bogdanos
Journal: Journal of Hepatology (2024)
SAT-542 Macrophage Dvl2-HSF1 axis regulates STING-mediated innate immunity and hepatocyte death in liver ischemia and reperfusion injury
Authors: Tao Yang, Dongwei Xu, Xiaoye Qu, Mingwei Sheng, Yuanbang Lin, Xiao Wang, Christopher King, Jun Li, Longfeng Jiang, Qiang Xia, Douglas Farmer, Bibo Ke
Journal: Journal of Hepatology (2024)
WED-009 Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation
Authors: Ângela Carvalho-Gomes, Laura Martínez-Arenas, Iván Sahuco, Almudena Cubells, Marina Berenguer, F. Xavier Lopez-Labrador, Victoria Aguilera Sancho
Journal: Journal of Hepatology (2024)
THU-177-YI Patient-reported outcomes in primary sclerosing cholangitis: an australian multicentre cohort perspective
Authors: Natassia Tan, Christopher Zampogna, Rohit Sawhney, Stephen Bloom, Kate Lynch, Nicholas Hannah, Siddharth Sood, Kate Collins, Avik Majumdar, Andrew Coulshed, Ken Liu, John Lubel, William Kemp, Stuart Roberts, Ammar Majeed
Journal: Journal of Hepatology (2024)
FRI-555 New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: a human and experimental study
Authors: Iker Uriarte, Eva Santamaria, Amaya Lopez-Pascual, Josep Maria Argemi, Maria U. Latasa, Elena Adan-Villaescusa, Ainara Irigaray-Miramon, Jose Maria Herranz, Maria Arechederra, Jorge Basualdo, Felipe Lucena, Fernando J. Corrales, Fernando Rotellar, Fernando Pardo, Grégory Merlen, Bruno Sangro, Thierry Tordjmann, Carmen Berasain, Maria J. Monte, Jose J.G. Marin, Maite G. Fernandez-Barrena, Jose Ignacio Herrero, Matías A. Avila
Journal: Journal of Hepatology (2024)
WED-540-YI Gender-dependent HCC development in X/MYC mouse model
Authors: Vincenzo Alfano, Alexia Paturel, Valerio Iebba, Giulia Canarutto, Massimiliano Cocca, Alice Lombard, Francesca De Nicola, Jamila Faivre, Silvano Piazza, Massimo Levrero, Claude Caron de Fromentel, Francesca Guerrieri
Journal: Journal of Hepatology (2024)
THU-540 Characterization of in vivo mouse models of regressive fibrosis and resolving portal hypertension
Authors: Katharina Bonitz, Philipp Königshofer, Benedikt Hofer, Oleksander Petrenko, Thomas Sorz, Vlad Taru, Benedikt Simbrunner, Henriette Horstmeier, Kerstin Zinober, Katharina Regnat, Hubert Scharnagl, Michael Trauner, Stefan Gunther Kauschke, Larissa Pfisterer, Peng Sun, Ines Truebenbach, Philipp Schwabl, Thomas Reiberger
Journal: Journal of Hepatology (2024)